AEterna Zentaris AEZS 1000% Chance !? (Seite 785)
eröffnet am 21.11.15 14:39:40 von
neuester Beitrag 18.04.23 19:48:47 von
neuester Beitrag 18.04.23 19:48:47 von
Beiträge: 9.063
ID: 1.221.897
ID: 1.221.897
Aufrufe heute: 1
Gesamt: 1.452.504
Gesamt: 1.452.504
Aktive User: 0
ISIN: CA0079756007 · WKN: A403TN · Symbol: ET80
7,8200
EUR
+0,26 %
+0,0200 EUR
Letzter Kurs 22.05.24 Tradegate
Neuigkeiten
TitelBeiträge |
---|
14.12.23 · Business Wire (engl.) |
Werte aus der Branche Biotechnologie
Wertpapier | Kurs | Perf. % |
---|---|---|
1,2700 | +52,83 | |
1,0800 | +28,56 | |
2,1800 | +27,49 | |
1,9900 | +20,61 | |
10.777,50 | +19,75 |
Wertpapier | Kurs | Perf. % |
---|---|---|
46,20 | -16,00 | |
0,5701 | -16,77 | |
2,5100 | -17,43 | |
2,2001 | -20,57 | |
0,5760 | -40,00 |
Beitrag zu dieser Diskussion schreiben
Antwort auf Beitrag Nr.: 51.318.960 von rosmo1 am 16.12.15 17:34:45In addition, the Company proposes to grant to the Underwriters an option (the “ Over-Allotment Option ”), in respect of their percentages set forth in Section 25(a) hereof, exercisable in whole or in part at any time prior to 5:00 p.m. (Toronto time) on the day that is the forty-fifth (45 th ) day following the Closing Date, in the Representative’s sole discretion and without obligation, to purchase from the Company up to an additional 330,000 Common Shares (the “ Option Shares ”) and Warrants (the “ Option Warrants ” and, collectively with the Option Shares, the “ Option Securities ”) to purchase up to 231,000 shares of common stock (the “ Option Warrant Shares ”), which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.
(b) Over-Allotment Option
(i) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “ Over-Allotment Option ”) to purchase, in the aggregate, up to 330,000 Option Shares and up to 231,000 Option Warrants, which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively. The Representative covenants and agrees that to the extent the Representative exercises the Over-Allotment Option on the Closing Date solely with respect to the Option Warrants, then such exercise shall be in an manner as contemplated and for the purpose as described in the Prospectus Supplements under the heading “ Underwriting – Underwriters’ Option ”.
19
(ii) In connection with an exercise of the Over-Allotment Option, (a) the purchase price to be paid for the Option Shares is equal to the product of the Share Purchase Price multiplied by the number of Option Shares to be purchased and (b) the purchase price to be paid for the Option Warrants is equal to the product of the Warrant Purchase Price multiplied by the number of Option Warrants (the aggregate purchase price to be paid on an Option Closing Date, the “ Option Closing Purchase Price ”).
(c) Underwriters’ Commission . In consideration of the Underwriters’ services to be rendered in connection with the Offering, the Company agrees to pay to the Underwriters an aggregate underwriting fee equal to seven percent (7%) of the gross proceeds of the Offering, such cash commission representing US$0.3878 per Share, US$0.0007 per Warrant, and, if applicable, US$0.3878 per Option Share and/or US$0.0007 per Option Warrant (the “ Underwriters’ Commission ”). The Underwriters’ Commission may be deducted by the Underwriters from the proceeds of sale of the Closing Securities on the Closing Date or the proceeds of sale of the Option Securities on the Option Closing Date, as applicable. In addition, the Company agrees to pay to the Underwriters, and in the manner specified by the Underwriters, all fees, disbursements and expenses incurred by the Underwriters in accordance with the provisions in Section 4 hereof.
(b) Over-Allotment Option
(i) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “ Over-Allotment Option ”) to purchase, in the aggregate, up to 330,000 Option Shares and up to 231,000 Option Warrants, which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively. The Representative covenants and agrees that to the extent the Representative exercises the Over-Allotment Option on the Closing Date solely with respect to the Option Warrants, then such exercise shall be in an manner as contemplated and for the purpose as described in the Prospectus Supplements under the heading “ Underwriting – Underwriters’ Option ”.
19
(ii) In connection with an exercise of the Over-Allotment Option, (a) the purchase price to be paid for the Option Shares is equal to the product of the Share Purchase Price multiplied by the number of Option Shares to be purchased and (b) the purchase price to be paid for the Option Warrants is equal to the product of the Warrant Purchase Price multiplied by the number of Option Warrants (the aggregate purchase price to be paid on an Option Closing Date, the “ Option Closing Purchase Price ”).
(c) Underwriters’ Commission . In consideration of the Underwriters’ services to be rendered in connection with the Offering, the Company agrees to pay to the Underwriters an aggregate underwriting fee equal to seven percent (7%) of the gross proceeds of the Offering, such cash commission representing US$0.3878 per Share, US$0.0007 per Warrant, and, if applicable, US$0.3878 per Option Share and/or US$0.0007 per Option Warrant (the “ Underwriters’ Commission ”). The Underwriters’ Commission may be deducted by the Underwriters from the proceeds of sale of the Closing Securities on the Closing Date or the proceeds of sale of the Option Securities on the Option Closing Date, as applicable. In addition, the Company agrees to pay to the Underwriters, and in the manner specified by the Underwriters, all fees, disbursements and expenses incurred by the Underwriters in accordance with the provisions in Section 4 hereof.